Quarterly report pursuant to Section 13 or 15(d)

Common Stock Warrants (Tables)

v3.20.1
Common Stock Warrants (Tables)
3 Months Ended
Mar. 31, 2020
Equity [Abstract]  
Summary of Warrant Activity

A summary of the Company’s warrant issuance activity and related information for the quarters ended March 31, 2020 and March 31, 2019:

 

    Shares    

Weighted

Average

Exercise

Price

   

Weighted

Average

Remaining

Contractual

Life

 
Assumed as of the January 8, 2019 merger     12,108,743     $ 1.38       2.60  
Issued     17,500,000       0.75       2.84  
Outstanding and exercisable at March 31, 2019     29,608,743     $ 1.00       2.63  
                         
Outstanding and exercisable at December 31, 2019     44,806,076     $ 0.78       4.59  
Issued     513,567       0.75       6.13  
Outstanding and exercisable at March 31, 2020     45,319,643     $ 0.78       4.61

Schedule of Assumptions for Warrants

The fair value of all warrants issued are determined by using the Black-Scholes valuation technique and were assigned based on the relative fair value of both the common stock and the warrants issued. The inputs used in the Black-Scholes valuation technique to value each of the warrants as of their respective issue dates are as follows:

 

Event Description   Date   Number of Warrants     H-CYTE Stock Price     Exercise Price of Warrant     Grant Date Fair Value     Life of Warrant   Risk Free Rate of Return (%)     Annualized Volatility Rate (%)  
Private placement   1/8/2019     5,000,000     $ 0.40     $ 0.75     $ 0.24     3 years     2.57       115.08  
Antidilution provision(1)   1/8/2019     2,023,438     $ 0.40     $ 0.40     $ 0.28     3 years     2.57       115.08  
Private placement   1/18/2019     6,000,000     $ 0.40     $ 0.75     $ 0.23     3 years     2.60       114.07  
Private placement   1/25/2019     1,250,000     $ 0.59     $ 0.75     $ 0.38     3 years     2.43       113.72  
Private placement   1/31/2019     437,500     $ 0.54     $ 0.75     $ 0.34     3 years     2.43       113.47  
Private placement   2/7/2019     750,000     $ 0.57     $ 0.75     $ 0.36     3 years     2.46       113.23  
Private placement   2/22/2019     375,000     $ 0.49     $ 0.75     $ 0.30     3 years     2.46       113.34  
Private placement   3/1/2019     125,000     $ 0.52     $ 0.75     $ 0.33     3 years     2.54       113.42  
Private placement   3/8/2019     150,000     $ 0.59     $ 0.75     $ 0.38     3 years     2.43       113.53  
Private placement   3/11/2019     2,475,000     $ 0.61     $ 0.75     $ 0.40     3 years     2.45       113.62  
Private placement   3/26/2019     500,000     $ 0.51     $ 0.75     $ 0.32     3 years     2.18       113.12  
Private placement   3/28/2019     375,000     $ 0.51     $ 0.75     $ 0.31     3 years     2.18       112.79  
Private placement   3/29/2019     62,500     $ 0.51     $ 0.75     $ 0.31     3 years     2.21       112.79  
Private placement   4/4/2019     500,000     $ 0.48     $ 0.75     $ 0.29     3 years     2.29       112.77  
Private placement   7/15/2019     200,000     $ 0.53     $ 1.00     $ 0.31     3 years     1.80       115.50  
Convertible debt extension   9/18/2019     424,000     $ 0.40     $ 0.75     $ 0.25     3 years     1.72       122.04  
Private placement of Series D Convertible Preferred Stock   11/15/2019     14,669,757     $ 0.28     $ 0.75     $ 0.19     10 years     1.84       89.75  
Short-term note related party   11/26/2019     400,000     $ 0.20     $ 0.75     $ 0.13     3 years     1.58       144.36  
Short-term note, related party   12/30/2019     171,429     $ 0.14     $ 0.75     $ 0.08     3 years     1.59       145.29  
Short-term note, related party   1/13/2020     268,571     $ 0.12     $ 0.75     $ 0.07     3 years     1.60       145.76  
Private placement of Series D Convertible Preferred Stock   1/17/2020     244,996     $ 0.15     $ 0.75     $ 0.13     10 years     1.84       144.32